A phase 2 single-arm study to assess clinical activity, efficacy and safety of enzalutamide (ENZA) with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer von Trudeau, Maureen E., Winer, Eric P., Steinberg, Joyce Leta, Liosatos, Maggie, Poondru, Srinivasu, Dydo, Michael Nicholas, Peterson, Amy C., Gradishar, William John

Volltext